Analysts: Sarepta Therapeutics Inc (AB3A.F)

AB3A.F on Frankfurt Stock Exchange

24.03EUR
10:44am EDT
Change (% chg)

€3.06 (+14.60%)
Prev Close
€20.97
Open
€22.42
Day's High
€24.03
Day's Low
€22.20
Volume
510
Avg. Vol
340
52-wk High
€25.77
52-wk Low
€9.62

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -1.21 December 22 May 2015

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 5 4 4 4
(2) OUTPERFORM 4 3 3 4
(3) HOLD 10 12 12 11
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.26 2.42 2.42 2.37

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-15 15 0.23 2.30 0.00 3.05
Quarter Ending Sep-15 15 0.23 2.10 0.00 18.36
Year Ending Dec-15 15 1.34 10.00 0.00 45.75
Year Ending Dec-16 16 53.67 163.40 0.00 127.41
Earnings (per share)
Quarter Ending Jun-15 16 -1.21 -0.91 -1.58 -0.99
Quarter Ending Sep-15 16 -1.21 -0.90 -1.62 -0.74
Year Ending Dec-15 18 -4.89 -3.17 -5.99 -3.03
Year Ending Dec-16 16 -3.75 -1.30 -5.87 -2.03

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-15 0.82 0.00 0.82 100.00
Quarter Ending Dec-14 1.56 0.03 1.53 98.27
Quarter Ending Sep-14 2.75 1.06 1.69 61.44
Quarter Ending Jun-14 4.30 2.58 1.72 39.98
Quarter Ending Mar-14 3.54 6.09 2.55 72.09
Earnings (per share)
Quarter Ending Mar-15 -1.00 -1.49 0.49 -48.26
Quarter Ending Dec-14 -0.82 -1.08 0.26 -32.47
Quarter Ending Sep-14 -0.96 -0.71 0.25 -25.72
Quarter Ending Jun-14 -0.76 -0.85 0.09 -12.24
Quarter Ending Mar-14 -0.80 -0.75 0.05 -5.91

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-15 0.23 0.23 0.83 0.83 3.05
Quarter Ending Sep-15 0.23 0.23 0.81 0.81 18.36
Year Ending Dec-15 1.34 1.34 3.12 3.12 45.75
Year Ending Dec-16 53.67 49.26 46.53 50.46 127.41
Earnings (per share)
Quarter Ending Jun-15 -1.21 -1.21 -1.06 -1.06 -0.99
Quarter Ending Sep-15 -1.21 -1.21 -0.90 -0.90 -0.74
Year Ending Dec-15 -4.89 -5.09 -4.25 -4.25 -3.03
Year Ending Dec-16 -3.75 -4.02 -3.27 -3.27 -2.03

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-15 0 0 0 7
Quarter Ending Sep-15 0 0 0 6
Year Ending Dec-15 0 0 0 8
Year Ending Dec-16 1 0 5 1
Earnings
Quarter Ending Jun-15 0 0 1 12
Quarter Ending Sep-15 0 0 1 14
Year Ending Dec-15 0 0 0 15
Year Ending Dec-16 3 0 3 11

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Sadif Analytics Prime
$25.00
Provider: ValuEngine, Inc.
$49.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks